Finance

Lists
ZLDPY:OTCMKTS
Zealand Pharma A S American Depository Receipt
$7.38
0.00%
(0.00) 1D
Nov 10, 10:03:16 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLDPY...
Mkt. cap
2.56B
Avg. vol.
9.00
Volume
0.00
52-wk high
$16.00
52-wk low
$7.31
Shares outstanding
358.05M
No. of employees
605
Mkt. cap
2.56B
Avg. vol.
9.00
Volume
0.00
52-wk high
$16.00
52-wk low
$7.31
Shares outstanding
358.05M
No. of employees
605
News stories
From web sources and news partners
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A S American Depository Receipt
CEOAdam Steensberg
Employees605
FoundedApr 1, 1997
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
68.92M
34.00M
4.49B
4.00M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
530.07M
469.00M
516.00M
572.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.81M
104.00M
116.00M
117.00M
Operating expense
621.88M
573.00M
632.00M
58.00M
Total operating expenses
621.88M
573.00M
632.00M
58.00M
Operating income
-552.97M
-539.00M
3.86B
-54.00M
Other non operating income
-7.23M
24.00M
-91.00M
-14.00M
EBT including unusual items
-406.51M
-394.00M
4.01B
-3.00M
EBT excluding unusual items
-460.20M
-375.00M
3.97B
16.00M
Income tax expense
-27.39M
-
89.00M
51.00M
Effective tax rate
6.74%
-
2.22%
-1,700.00%
Other operating expenses
1.00K
-
-
-631.00M
Net income
-379.12M
-394.00M
3.92B
-54.00M
Net profit margin
-550.12%
-1,158.82%
87.22%
-1,350.00%
Earnings per share
-5.19
-5.58
55.34
-10.02
Interest and investment income
102.41M
74.00M
72.00M
72.00M
Interest expense
-7.07M
-5.00M
-8.00M
-8.00M
Net interest expenses
95.34M
69.00M
64.00M
64.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-550.48M
-529.00M
3.87B
-43.00M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps